Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armour, J. C.
Right arrow Articles by Gough, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armour, J. C.
Right arrow Articles by Gough, D. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 39, Issue 12 1519-1526, Copyright © 1990 by American Diabetes Association


ARTICLES

Application of chronic intravascular blood glucose sensor in dogs

JC Armour, JY Lucisano, BD McKean and DA Gough
Department of Applied Mechanics and Engineering Sciences, University of California, San Diego, La Jolla 92093.

An intravenous glucose sensor was implanted in six dogs for 1-15 wk. The glucose sensor is a flexible cylinder, approximately 0.2 cm diam and 30 cm long, with a tip containing immobilized glucose oxidase and catalase coupled to a potentiostatic O2 sensor. The sensor and a similar O2 reference sensor were implanted in the superior vena cava near the entrance of the right atrium. The sensor response was conveyed externally either by a telemetry system implanted nearby, surgically accessed leads, or chronically maintained percutaneous leads. Summing over the six implants, there was a total implantation period of 333 days during which glucose sensors were functional on demand. The sensor response showed agreement with conventionally assayed blood samples after accounting for a response lag. Sensor response to glucose showed little change over the implant period. Biocompatibility, enzyme lifetime, O2 availability, O2 sensor stability, and biochemical interference were not limitations. Results demonstrated that this sensor can function effectively as an implant in dogs for a period of months and has the potential for long-term operation.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. T. Makale, P. C. Chen, and D. A. Gough
Variants of the tissue-sensor array window chamber
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H57 - H65.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. T. Makale, J. T. Lin, R. E. Calou, A. G. Tsai, P. C. Chen, and D. A. Gough
Tissue window chamber system for validation of implanted oxygen sensors
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2288 - H2294.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Reach
Which Threshold to Detect Hypoglycemia?: Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity
Diabetes Care, May 1, 2001; 24(5): 803 - 804.
[Full Text]


Home page
BMJHome page
J. Pickup, L. McCartney, O. Rolinski, and D. Birch
In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring
BMJ, November 13, 1999; 319(7220): 1289 - 1289.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1990 by the American Diabetes Association.